1. Market Research
  2. > Biotechnology
  3. > Medical Biotechnology Market Trends
  4. > Global Medical Biotechnology Analysis & Statistics

Global Medical Biotechnology Analysis & Statistics

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Firstword Pharma

All regions

1-9 of 9 reports

Atopic Dermatitis: Update Bulletin #2 [March 2018]

  • $ 1151
  • March 2018
  • 1 pages

This edition presents key opinion leader (KOL) views on recent developments in the treatment of atopic dermatitis (AD). Topics covered include KOL views on; Pfizer’s announcement of initiation of the ...

  • Biopharmaceutical
  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • World

Commercialisaton of Biosimilars: Multifunctional teamwork for success

  • $ 2537
  • November 2017
  • 1 pages

Commercialisation of Biosimilars From bench to bedside, biosimilars continue to dominate boardroom discussions around the world. But after all the talking, what’s the secret to success in this high ...

  • Biosimilar
  • Medical Biotechnology
  • World

Commercialisation of Biologics: Benchmarking leading players

  • $ 2537
  • October 2017
  • 1 pages

Commercialisation of Biologics: Benchmarking Leading Players It’s clear that the rapidly growing biologics sector holds a wealth of promise. The significant opportunities resulting from breaking new ...

  • Biopharmaceutical
  • Medical Biotechnology
  • World

Biosimilars Real World Evidence: Proving the point

  • $ 2537
  • July 2017
  • 1 pages

Biosimilars Real World Evidence: Proving the point Biosimilar manufacturers face an uphill struggle to fully mobilise their product portfolio. Against a background of aggressive defence strategies by ...

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • World

Targeted Therapies in Asthma: KOL Insight: Update Bulletin [April 2017]

  • $ 1112
  • April 2017
  • 1 pages

This edition presents key opinion leader (KOL) views on recent developments in the targeted asthma treatment market Topics covered include; GlaxoSmithKline’s (GSK) presentation of new data at the American ...

  • Medical Biotechnology
  • Monoclonal Antibody
  • Salicylic Acid
  • Therapy
  • World

Biosimilars Education: Addressing a significant unmet need

  • $ 2537
  • November 2016
  • 1 pages

Description How to educate stakeholders about biosimilar benefits What information and data do physicians, payers and patients need about biosimilars? benefits As the market expands and new therapeutic ...

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • United States
  • World

Biosimilars: Regulatory Outlook

  • $ 2337
  • November 2015
  • 1 pages

Biosimilars offer a chance to improve access to, and reduce spending on, life-saving biologic therapies. But could regulators do more to support the market? While experts believe significant regulatory ...

  • Biosimilar
  • Medical Biotechnology
  • United States
  • World
  • Regulation

Physician Views: Are neurologists ready to embrace gene therapy?

  • $ 781
  • June 2014
  • 1 pages

As recently noted by Forbes, the biotech bull market of 2013 has helped to revive an approach to drug development that had become largely abandoned and pursued by only a few devoted believers. Between ...

  • Gene Therapy
  • Medical Biotechnology
  • Psychotic Disorder
  • Therapy
  • World

Biosimilar Index: Tracking the Biosimilar Development Landscape

  • $ 5295
  • April 2014
  • 135 pages

FirstWord’s Biosimilar Index is a comprehensive drug intelligence service that provides a robust, dynamically updated and highly-detailed insight into the status of leading biosimilar and NCB assets ...

  • Biosimilar
  • Medical Biotechnology
  • World



Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on